News

Hisense, a global leader in consumer electronics and home appliances, has been recognised as the world's fastest-growing ...
American Copper Development Corporation (CSE: ACDX) ("ACDX" or the " Company") announces a non-brokered private placement (the "Private ...
Premium Catering (Holdings) Limited ("PC" or the "Company") (Nasdaq: PC), previously announced a Share Consolidation ("Reverse Split") of its Class A Ordinary ...
SALINAS, CA / ACCESS Newswire / July 21, 2025 / Taylor Farms, North America's premier provider of ready-to-enjoy salads and healthy fresh foods, proudly announces the awarding of over $650,000 in scho ...
TORONTO, ON / ACCESS Newswire / July 21, 2025 / Galway Metals Inc. (TSXV:GWM)(OTCQB:GAYMF) (the "company" or "Galway Metals"), is pleased to announce an update on recent insider purchases, through a s ...
SILICON METALS CORP. (CSE: SI) (FSE: X6U) ("Silicon Metals" or the "Company") announces that, further to its news release dated July 15 ...
BURNABY, BC / ACCESS Newswire / July 21, 2025 / Ostrom Climate Solutions Inc. ("Ostrom" or the "Company") (TSXV:COO)(Frankfurt:9EAA), a leading provider of carbon project development and climate solut ...
NORTH BILLERICA, MA / ACCESS Newswire / July 21, 2025 / Tecogen Inc. ("Tecogen" or "Company"), (NYSE American:TGEN), a leading manufacturer of clean energy products, today announced the closing of its ...
Further increase in a tense market environment and an unfavorable base effect A 2nd half of 2025 expected to see sustained growth, driven by the implementation of the Ukraine contract and the accelera ...
AMETEK, Inc. today announced that it has completed its acquisition of FARO Technologies, a global leader in 3D measurement and imaging solutions. FARO ...
Upon Completion of the 10-Q Quarterly Interim Review filing, Cytta Corp will be Current and Will Regain OTCQB Status LAS VEGAS, NEVADA / ACCESS Newswire / July 21, 2025 / Cytta Corp. (OTCExpertMarket: ...
Findings published in the journal of Clinical Genitourinary Cancer show patients remained event-free for a median of two years after achieving complete response with ZUSDURI (mitomycin) intravesical ...